Vitamin D supplementation for the treatment of Behcet's disease
Phase 2
- Conditions
- Behcet's disease.Behçet disease
- Registration Number
- IRCT201212216975N4
- Lead Sponsor
- Vice chancellor for research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Having active Behcet’s disease: Iranian Behcet's Disease Dynamic Activity Measure (IBDDAM) more than 2.5
Exclusion criteria:
1. Consumption of vitamin D supplements in the past 6 months
2. Pregnancy
3. Malabsorption
4. Renal failure
5. Hepatic failure
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Behcet's disease activity. Timepoint: Before intervention, 3 and 6 months after intervention. Method of measurement: Iranian Behcet’s Disease Dynamic Activity Measure questionnaire.
- Secondary Outcome Measures
Name Time Method Complications of vitamin D supplementation. Timepoint: 3 and 6 months after the intervention. Method of measurement: History and physical examination.